Mitoxantrone hydrochloride was the first FDA-approved medication for both secondary-progressive multiple sclerosis (MS) and progressive-relapsing MS. It’s also used to treat relapsing-remitting MS ...

Investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have discovered how a drug for multiple sclerosis interacts with its targets, a finding that may pave the way for ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

A single dose of Immutep’s MS therapy, IMP761, was well tolerated and reduced T-cell activity for up to 23 days in healthy ...

A team of researchers at Kessler Foundation studied the effects of methylphenidate on mental fatigue in individuals with multiple sclerosis (MS). This is the first study to examine the psychostimulant ...

How Does Ocrevus or Ocrevus Zunovo Work in MS? MS happens when your immune system damages the protective covering around the nerves in your brain, called myelin. This affects how your brain ...

Multiple sclerosis affects your abilities and the way your body functions, and this sometimes includes sexual function. Damage to the brain and spinal cord in MS can contribute to erectile dysfunction ...

The over‐the‐counter supplement lipoic acid may have a small beneficial effect in slowing the loss of gray matter in the brains of people with progressive forms of multiple sclerosis, according to new ...

—To clarify the role that stigma plays in the mental health and quality of life in people with MS, researchers conducted an MS-specific retrospective data review. They found that stigma was associated ...

Share on Pinterest A biosimilar of a monoclonal antibody has been approved by the FDA to treat MS. Portra/Getty Images The Food and Drug Administration approved the first biosimilar to treat relapsing ...